Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 12,549	$ 2,932
General and administrative	4,472	1,784
Total operating expenses	17,021	4,716
Loss from operations	(17,021)	(4,716)
Other income (expense):
Interest income	26	2
Interest expense	(118)	0
Other Income	315	0
Change in fair value of non-marketable equity securities	(287)	0
Total other (expense) income	(64)	2
Net loss	(17,085)	(4,714)
Change in unrealized loss on marketable securities	(12)
Total loss and other comprehensive loss	$ (17,097)	$ 4,714
Net loss per share attributable to common stockholders, basic and diluted	$ (0.71)	$ (12.23)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	24,227,282	385,401